The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peptide-Based Drug Delivery System Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Peptide-Based Drug Delivery System Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1755979

No of Pages : 104

Ask Your Query

Synopsis
The global Peptide-Based Drug Delivery System market size was valued at USD 33080 million in 2022 and is forecast to a readjusted size of USD 43880 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Key market drivers for peptide-based drug delivery systems is the growing demand for targeted and personalized therapies. Peptides offer the advantage of high specificity and affinity for specific receptors or cell types, allowing for precise delivery of drugs to the desired sites in the body. This targeted approach enhances therapeutic efficacy while minimizing off-target effects and reducing systemic toxicity.

A peptide-based drug delivery system refers to a technology or formulation that utilizes peptides to improve the delivery, targeting, and release of therapeutic drugs. These systems are designed to enhance the efficacy, bioavailability, and safety of drugs by specifically delivering them to the desired site of action in the body.

This report is a detailed and comprehensive analysis for global Peptide-Based Drug Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Peptide-Based Drug Delivery System market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Peptide-Based Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Peptide-Based Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Peptide-Based Drug Delivery System market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Peptide-Based Drug Delivery System
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Peptide-Based Drug Delivery System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Novo Nordisk, Takeda and Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Peptide-Based Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Brand
  • Generic Drug

Market segment by Application

  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other

Market segment by players, this report covers

  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • AbbVie
  • Ipsen
  • Ferring
  • Merck
  • The Medicines
  • Roche
  • J & J

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Peptide-Based Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide-Based Drug Delivery System, with revenue, gross margin and global market share of Peptide-Based Drug Delivery System from 2018 to 2023.
Chapter 3, the Peptide-Based Drug Delivery System competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Peptide-Based Drug Delivery System market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide-Based Drug Delivery System.
Chapter 13, to describe Peptide-Based Drug Delivery System research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Peptide-Based Drug Delivery System
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Peptide-Based Drug Delivery System by Type
1.3.1 Overview: Global Peptide-Based Drug Delivery System Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Peptide-Based Drug Delivery System Consumption Value Market Share by Type in 2022
1.3.3 Brand
1.3.4 Generic Drug
1.4 Global Peptide-Based Drug Delivery System Market by Application
1.4.1 Overview: Global Peptide-Based Drug Delivery System Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Metabolic Disorders
1.4.4 Central Nervous System
1.4.5 Other
1.5 Global Peptide-Based Drug Delivery System Market Size & Forecast
1.6 Global Peptide-Based Drug Delivery System Market Size and Forecast by Region
1.6.1 Global Peptide-Based Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Peptide-Based Drug Delivery System Market Size by Region, (2018-2029)
1.6.3 North America Peptide-Based Drug Delivery System Market Size and Prospect (2018-2029)
1.6.4 Europe Peptide-Based Drug Delivery System Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Peptide-Based Drug Delivery System Market Size and Prospect (2018-2029)
1.6.6 South America Peptide-Based Drug Delivery System Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Peptide-Based Drug Delivery System Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Peptide-Based Drug Delivery System Product and Solutions
2.1.4 Sanofi Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Peptide-Based Drug Delivery System Product and Solutions
2.2.4 Teva Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments and Future Plans
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business
2.3.3 Novo Nordisk Peptide-Based Drug Delivery System Product and Solutions
2.3.4 Novo Nordisk Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk Recent Developments and Future Plans
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Peptide-Based Drug Delivery System Product and Solutions
2.4.4 Takeda Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Takeda Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Peptide-Based Drug Delivery System Product and Solutions
2.5.4 Eli Lilly Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Peptide-Based Drug Delivery System Product and Solutions
2.6.4 AstraZeneca Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Peptide-Based Drug Delivery System Product and Solutions
2.7.4 Novartis Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Peptide-Based Drug Delivery System Product and Solutions
2.8.4 AbbVie Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Ipsen
2.9.1 Ipsen Details
2.9.2 Ipsen Major Business
2.9.3 Ipsen Peptide-Based Drug Delivery System Product and Solutions
2.9.4 Ipsen Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ipsen Recent Developments and Future Plans
2.10 Ferring
2.10.1 Ferring Details
2.10.2 Ferring Major Business
2.10.3 Ferring Peptide-Based Drug Delivery System Product and Solutions
2.10.4 Ferring Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ferring Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Peptide-Based Drug Delivery System Product and Solutions
2.11.4 Merck Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck Recent Developments and Future Plans
2.12 The Medicines
2.12.1 The Medicines Details
2.12.2 The Medicines Major Business
2.12.3 The Medicines Peptide-Based Drug Delivery System Product and Solutions
2.12.4 The Medicines Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 The Medicines Recent Developments and Future Plans
2.13 Roche
2.13.1 Roche Details
2.13.2 Roche Major Business
2.13.3 Roche Peptide-Based Drug Delivery System Product and Solutions
2.13.4 Roche Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Roche Recent Developments and Future Plans
2.14 J & J
2.14.1 J & J Details
2.14.2 J & J Major Business
2.14.3 J & J Peptide-Based Drug Delivery System Product and Solutions
2.14.4 J & J Peptide-Based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 J & J Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Peptide-Based Drug Delivery System Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Peptide-Based Drug Delivery System by Company Revenue
3.2.2 Top 3 Peptide-Based Drug Delivery System Players Market Share in 2022
3.2.3 Top 6 Peptide-Based Drug Delivery System Players Market Share in 2022
3.3 Peptide-Based Drug Delivery System Market: Overall Company Footprint Analysis
3.3.1 Peptide-Based Drug Delivery System Market: Region Footprint
3.3.2 Peptide-Based Drug Delivery System Market: Company Product Type Footprint
3.3.3 Peptide-Based Drug Delivery System Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Peptide-Based Drug Delivery System Consumption Value and Market Share by Type (2018-2023)
4.2 Global Peptide-Based Drug Delivery System Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Peptide-Based Drug Delivery System Consumption Value Market Share by Application (2018-2023)
5.2 Global Peptide-Based Drug Delivery System Market Forecast by Application (2024-2029)
6 North America
6.1 North America Peptide-Based Drug Delivery System Consumption Value by Type (2018-2029)
6.2 North America Peptide-Based Drug Delivery System Consumption Value by Application (2018-2029)
6.3 North America Peptide-Based Drug Delivery System Market Size by Country
6.3.1 North America Peptide-Based Drug Delivery System Consumption Value by Country (2018-2029)
6.3.2 United States Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
6.3.3 Canada Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
6.3.4 Mexico Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Peptide-Based Drug Delivery System Consumption Value by Type (2018-2029)
7.2 Europe Peptide-Based Drug Delivery System Consumption Value by Application (2018-2029)
7.3 Europe Peptide-Based Drug Delivery System Market Size by Country
7.3.1 Europe Peptide-Based Drug Delivery System Consumption Value by Country (2018-2029)
7.3.2 Germany Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
7.3.3 France Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
7.3.5 Russia Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
7.3.6 Italy Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Peptide-Based Drug Delivery System Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Peptide-Based Drug Delivery System Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region
8.3.1 Asia-Pacific Peptide-Based Drug Delivery System Consumption Value by Region (2018-2029)
8.3.2 China Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8.3.3 Japan Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8.3.4 South Korea Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8.3.5 India Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
8.3.7 Australia Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
9 South America
9.1 South America Peptide-Based Drug Delivery System Consumption Value by Type (2018-2029)
9.2 South America Peptide-Based Drug Delivery System Consumption Value by Application (2018-2029)
9.3 South America Peptide-Based Drug Delivery System Market Size by Country
9.3.1 South America Peptide-Based Drug Delivery System Consumption Value by Country (2018-2029)
9.3.2 Brazil Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
9.3.3 Argentina Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Peptide-Based Drug Delivery System Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Peptide-Based Drug Delivery System Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country
10.3.1 Middle East & Africa Peptide-Based Drug Delivery System Consumption Value by Country (2018-2029)
10.3.2 Turkey Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
10.3.4 UAE Peptide-Based Drug Delivery System Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Peptide-Based Drug Delivery System Market Drivers
11.2 Peptide-Based Drug Delivery System Market Restraints
11.3 Peptide-Based Drug Delivery System Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Peptide-Based Drug Delivery System Industry Chain
12.2 Peptide-Based Drug Delivery System Upstream Analysis
12.3 Peptide-Based Drug Delivery System Midstream Analysis
12.4 Peptide-Based Drug Delivery System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock